Position in ORGO
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$41,885
+$1,034 QoQ
Shares Held
17,237
0.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 134 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Metis Global Partners, LLC holds $4,199,495 across 6 Drug Manufacturers - Specialty & Generic names. ORGO ranks #6 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
37,537 | $2,697,408 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
28,999 | $982,486 | |
| 3 | VTRS |
Viatris Inc
|
21,618 | $343,293 | |
| 4 | KMDA |
Kamada Ltd
|
12,479 | $91,595 | |
| 5 | SIGA |
Siga Technologies Inc
|
11,766 | $42,828 | |
| 6 | ORGO |
Organogenesis Holdings Inc.
This page
|
17,237 | $41,885 |
All Filings in ORGO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,885 | 17,237 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $40,851 | 17,237 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $151,872 | 29,319 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $123,726 | 29,319 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $107,307 | 29,319 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $126,658 | 29,319 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $93,820 | 29,319 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $83,852 | 29,319 | Shares | Sole | 2024-11-06 | |
| No filing history on record for this holder in this stock. | ||||||